PMC:7461420 / 96077-96240
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T345","span":{"begin":117,"end":121},"obj":"Body_part"}],"attributes":[{"id":"A345","pred":"fma_id","subj":"T345","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"Studies for colchicine as an anti‐SARS‐CoV‐2 agent are currently ongoing with the aim of curtailing inflammation and lung complications in mild COVID‐19 cases. 244"}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T29","span":{"begin":117,"end":121},"obj":"Body_part"}],"attributes":[{"id":"A29","pred":"uberon_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Studies for colchicine as an anti‐SARS‐CoV‐2 agent are currently ongoing with the aim of curtailing inflammation and lung complications in mild COVID‐19 cases. 244"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T455","span":{"begin":34,"end":38},"obj":"Disease"},{"id":"T456","span":{"begin":100,"end":112},"obj":"Disease"},{"id":"T457","span":{"begin":144,"end":152},"obj":"Disease"}],"attributes":[{"id":"A455","pred":"mondo_id","subj":"T455","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A456","pred":"mondo_id","subj":"T456","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A457","pred":"mondo_id","subj":"T457","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Studies for colchicine as an anti‐SARS‐CoV‐2 agent are currently ongoing with the aim of curtailing inflammation and lung complications in mild COVID‐19 cases. 244"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1078","span":{"begin":82,"end":85},"obj":"http://purl.obolibrary.org/obo/PR_000001343"},{"id":"T1079","span":{"begin":117,"end":121},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T1080","span":{"begin":117,"end":121},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"Studies for colchicine as an anti‐SARS‐CoV‐2 agent are currently ongoing with the aim of curtailing inflammation and lung complications in mild COVID‐19 cases. 244"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T719","span":{"begin":12,"end":22},"obj":"Chemical"}],"attributes":[{"id":"A719","pred":"chebi_id","subj":"T719","obj":"http://purl.obolibrary.org/obo/CHEBI_23359"}],"text":"Studies for colchicine as an anti‐SARS‐CoV‐2 agent are currently ongoing with the aim of curtailing inflammation and lung complications in mild COVID‐19 cases. 244"}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T128","span":{"begin":100,"end":112},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"Studies for colchicine as an anti‐SARS‐CoV‐2 agent are currently ongoing with the aim of curtailing inflammation and lung complications in mild COVID‐19 cases. 244"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"2937","span":{"begin":34,"end":44},"obj":"Species"},{"id":"2938","span":{"begin":12,"end":22},"obj":"Chemical"},{"id":"2939","span":{"begin":100,"end":112},"obj":"Disease"},{"id":"2940","span":{"begin":117,"end":135},"obj":"Disease"},{"id":"2941","span":{"begin":144,"end":152},"obj":"Disease"}],"attributes":[{"id":"A2937","pred":"tao:has_database_id","subj":"2937","obj":"Tax:2697049"},{"id":"A2938","pred":"tao:has_database_id","subj":"2938","obj":"MESH:D003078"},{"id":"A2939","pred":"tao:has_database_id","subj":"2939","obj":"MESH:D007249"},{"id":"A2940","pred":"tao:has_database_id","subj":"2940","obj":"MESH:D008171"},{"id":"A2941","pred":"tao:has_database_id","subj":"2941","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Studies for colchicine as an anti‐SARS‐CoV‐2 agent are currently ongoing with the aim of curtailing inflammation and lung complications in mild COVID‐19 cases. 244"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T853","span":{"begin":0,"end":159},"obj":"Sentence"},{"id":"T854","span":{"begin":160,"end":163},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Studies for colchicine as an anti‐SARS‐CoV‐2 agent are currently ongoing with the aim of curtailing inflammation and lung complications in mild COVID‐19 cases. 244"}